Pediatrix Medical Group, Inc.

NYSE:MD

Medical - Care Facilities

Healthcare
$30.84 -2.04%

-$0.48 today

Market cap
$2.41B
Beta
0.70
P/E (TTM)
11.0
EPS (TTM)
$2.10
52W Low $11.84High $24.99

Volume 0.64M

Average 0.82M

MD EBITDA Margin

EBITDA as a percentage of revenue.

Pediatrix Medical Group, Inc.NYSE: MD

EBITDA Margin · Q3 FY2026 · quarter ended Sep 2026

EBITDA Margin narrows to 15.8%

EBITDA Margin was 15.8% in Q3 FY2026, down 3.7 pp from a year earlier. On a trailing-twelve-month basis it was 12.8%, down 0.7 pp year over year. Over 3 fiscal years it widened by 6.4 pp.

Context

  • EBITDA Margin widened in 1 of the last 3 fiscal years.
  • FY2025 was the highest level in the 4 fiscal years shown.

What to watch

Whether EBITDA Margin reaches the consensus estimate from 6 analysts of 14.6% for the fiscal year ending Dec 2026, up from 14.3% in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterSep 2026
15.8%+4.1 pp QoQ
Last fiscal yearDec 2025
14.3%+15.7 pp YoY
LTMSep 2026
12.8%-0.7 pp YoY
EBITDA Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter-3.7 pp+1.8 pp+5.5 pp
1 year+15.7 pp+0.3 pp-15.4 pp
3 years+6.4 pp+0.9 pp-5.4 pp
5 years——
10 years——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

EBITDA Margin history

Percent of revenue · from the income statement

Latest · FY2025
14.3%
Year-over-year change
+15.7pp
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

EBITDA Margin vs competitors

How MD compares with its peers on the latest reported figures

  • MD's LTM Sep 2026 EBITDA Margin of 12.8% is the 4th highest of the 11 companies compared; the peer median is 8.8%.
  • Its year-over-year change of -0.7 pp is the 7th highest of 11, against a peer median of +0.6 pp.
  • Over three fiscal years its change of +6.4 pp compares with a peer median of -0.6 pp.
MD Competitors Peer median
EBITDA Margin for MD and competitors
Company Period LTM level YoY 3-year change
OGNOrganon & Co.LTM Sep 202621.2% -3.6 pp-7.7 pp
NHCNational HealthCare CorporationLTM Sep 202613.1% +0.5 pp+7.7 pp
AVAHAveanna Healthcare Holdings Inc.LTM Oct 202613.0% +1.4 pp+40.8 pp
MDPediatrix Medical Group, Inc.LTM Sep 202612.8% -0.7 pp+6.4 pp
ADUSAddus HomeCare CorporationLTM Jun 202611.3% +0.7 pp+2.0 pp
SEMSelect Medical Holdings CorporationLTM Mar 20269.4% +1.7 pp-0.3 pp
LFSTLifeStance Health Group, Inc.LTM Jun 20268.3% +4.0 pp+22.2 pp
GRDNGuardian Pharmacy Services, Inc.LTM Jun 20268.2% +11.3 pp-0.8 pp
ARDTArdent Health Partners, LLCLTM Mar 20267.9% -1.5 pp-2.5 pp
ASTHAstrana Health, Inc.LTM Mar 20264.6% -1.1 pp-5.5 pp
ACHCAcadia Healthcare Company, Inc.LTM Sep 2026-19.5% -33.4 pp-43.8 pp
Peer median (excluding MD) 8.8%+0.6 pp-0.6 pp

Competitors are the stored peer set for MD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue1.91B1.97B1.99B2.01B1.91B
Cost of Revenue1.4B1.5B1.57B1.56B1.44B
Gross Profit513.24M467.03M421.57M454.34M471.88M
Gross Margin26.9%23.7%21.1%22.6%24.7%
Research & Development00000
Selling, General & Admin263.36M231.4M227.54M238.44M240.79M
Operating Expenses310.32M294.35M414.24M523.06M240.79M
Depreciation & Amortization32.15M35.64M36.17M32.23M21.83M
EBITDA236.1M156.7M29.89M(28.37M)274.22M
EBITDA Margin12.4%7.9%1.5%-1.4%14.3%
Operating Income202.92M172.69M7.32M(68.71M)231.09M
Operating Margin10.6%8.8%0.4%-3.4%12.1%
Interest Income000019.05M
Interest Expense68.72M39.7M42.08M40.74M35.97M
Other Income / Expenses(67.69M)(91.32M)(55.68M)(32.63M)(14.65M)
Income Before Tax135.23M81.37M(48.36M)(101.34M)216.43M
Pre-Tax Margin7.1%4.1%-2.4%-5.0%11.3%
Income Tax Expense27.24M18.81M12.05M(2.27M)51.04M
Net Income130.96M66.34M(60.41M)(99.07M)165.39M
Net Margin6.9%3.4%-3.0%-4.9%8.6%
EPS (Basic)1.520.80(0.73)(1.19)1.94
EPS (Diluted)1.520.79(0.73)(1.19)1.94
Weighted Avg Shares86.42M82.95M82.2M83.33M85.27M
Weighted Avg Shares (Diluted)86.42M84.12M82.2M83.33M85.27M

Pediatrix Medical Group, Inc.

NYSE:MD

Intrinsic Alpha fair value

Locked

Current Price

$30.84

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.